Your browser doesn't support javascript.
loading
A Comparison of Presentation, Treatment, and Survival After Hepatocellular Carcinoma of Viral and Non-Viral Etiology in Damietta, Egypt, 2007-2019.
Jean, Kévin; Tawheed, Ahmed; Luong Nguyen, Liem Binh; Heikal, Tarek; Eldaly, Usama; Gaber Elhadidy, Neveen; Elghaieb, Ahmed; Aboudonia, Ahmed; Tondeur, Laura; Dublineau, Amélie; Fontanet, Arnaud; El-Kassas, Mohamed.
Afiliação
  • Jean K; Laboratoire MESuRS, Conservatoire national des arts et métiers, Paris, France.
  • Tawheed A; Unité PACRI, Institut Pasteur & Conservatoire national des arts et métiers, Paris, France.
  • Luong Nguyen LB; IBENS, École Normale Supérieure, CNRS, INSERM, Université Paris Science & Lettres, Paris, France.
  • Heikal T; Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt.
  • Eldaly U; Emerging Diseases Epidemiology Unit, Institut Pasteur, Université Paris-Cité, Paris, France.
  • Gaber Elhadidy N; Medical Oncology Department, Damietta Oncology Center, Damietta, Egypt.
  • Elghaieb A; Medical Oncology Department, Damietta Oncology Center, Damietta, Egypt.
  • Aboudonia A; Pharmaceutical Services Department, Damietta Oncology Center, Damietta, Egypt.
  • Tondeur L; Radiology Department, Damietta Oncology Center, Damietta, Egypt.
  • Dublineau A; Radiology Department, Damietta Oncology Center, Damietta, Egypt.
  • Fontanet A; Emerging Diseases Epidemiology Unit, Institut Pasteur, Université Paris-Cité, Paris, France.
  • El-Kassas M; Emerging Diseases Epidemiology Unit, Institut Pasteur, Université Paris-Cité, Paris, France.
J Hepatocell Carcinoma ; 11: 997-1004, 2024.
Article em En | MEDLINE | ID: mdl-38835726
ABSTRACT
Context The difference in prognosis between patients diagnosed with viral versus non-viral hepatocellular carcinoma (HCC) in Egypt remains unclear.

Methods:

We used data from patients diagnosed with HCC between 2007 and 2019 from a large monocentric retrospective cohort at the Damietta Oncology referral center (northern Egypt). Presentation and treatment were compared between viral versus non-viral etiology HCC patients. Survival was compared relying on univariate and multivariate Cox regressions.

Results:

Data from 4714 HCC patients were analyzed. Among them, 204 (4.3%) presented with a non-viral etiology. Patients with non-viral versus viral etiology had a similar presentation overall, especially regarding the BCLC stage at HCC diagnosis. After controlling for various individual characteristics, patients with non-viral versus viral etiology had poorer survival (adjusted Hazard Ratio 1.244; 95% Confidence Interval 1.069-1.447).

Conclusion:

Despite similar features, patients with non-viral- related HCC had poorer survival compared to patients with viral-related HCC.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Hepatocell Carcinoma Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Hepatocell Carcinoma Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França